logo
Plus   Neg
Share
Email

New Oriental Issues Q4 Revenue Guidance - Quick Facts

New Oriental Education & Technology Group Inc. (EDU) announced the company expects total net revenues in the fourth quarter of to be in the range of $774.0 million to $806.2 million, a year-over-year decline in the range of 8% to 4%. The company anticipates the impact on its business from the outbreak of COVID-19 pandemics around the globe will continue during the fourth quarter, especially on overseas related businesses including test preparation and consulting business.

Third-quarter non-GAAP net income per ADS was $0.93 compared to $0.69, prior year. Total net revenues increased by 15.9% year-over-year to $923.2 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
Follow RTT